题名 | mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo |
作者 | |
发表日期 | 2013-12-01 |
发表期刊 | CANCER LETTERS 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Cancer stem cells Nasopharyngeal carcinoma mTOR signaling Rapamycin |
其他关键词 | GROWTH-FACTOR RECEPTOR ; BREAST-CANCER ; RIBOSOMAL-PROTEIN ; SIGNALING PATHWAY ; STEM-CELLS ; EXPRESSION ; IDENTIFICATION ; MARKER ; PHOSPHORYLATION ; RESISTANCE |
摘要 | The mammalian target of rapamycin (mTOR) signaling is a key pathway in the progression of different cancers and in the homeostasis of stem cells. Here, we investigated the link between mTOR signaling and cancer stem cells (CSCs) in nasopharyngeal carcinoma (NPC). We found that human primary NPC expressed embryonic stem cell (ESC) markers: CD133, SOX2 and OCT4 as well as pmTOR and pS6. Primary ESC-positive NPC cells could form secondary NPC in BALB/c nude mice. Rapamycin, an mTOR inhibitor, significantly suppressed ESC-positive NPC cell growth in vitro and tumor formation in vivo. Our findings suggest that mTOR signaling is activated in CSC-like cells and plays an important role in NPC growth. (C) 2013 Elsevier Ireland Ltd. All rights reserved. |
资助项目 | Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [Y12H160047]; Wenzhou Science and Technology Bureau [H20080025]; Wenzhou Medical College |
出版者 | ELSEVIER IRELAND LTD |
出版地 | CLARE |
ISSN | 0304-3835 |
EISSN | 1872-7980 |
卷号 | 341期号:2页码:186-194 |
DOI | 10.1016/j.canlet.2013.08.004 |
页数 | 9 |
WOS类目 | Oncology |
WOS研究方向 | Oncology |
WOS记录号 | WOS:000328096300009 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 23933173 |
SCOPUSEID | 2-s2.0-84887178635 |
通讯作者地址 | [Zhang, Yue]Department of Otolaryngology, The First Affiliated Hospital,Wenzhou Medical College,China |
Scopus学科分类 | Oncology;Cancer Research |
TOP期刊 | TOP期刊 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/17604 |
专题 | 附属第一医院 |
通讯作者 | Zhang, Yue |
作者单位 | 1.Department of Otolaryngology,First Affiliated Hospital,Wenzhou Medical University,China; 2.Department of Pathology,First Affiliated Hospital,Wenzhou Medical University,China; 3.Department of Clinical Oncology,Queen Elizabeth Hospital,Hong Kong; 4.Department of Pharmacology and Neuroscience,University of North Texas Health Science Center at Fort Worth,United States |
第一作者单位 | 附属第一医院 |
通讯作者单位 | 第一临床医学院(信息与工程学院)、附属第一医院; 附属第一医院 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Yang, Chunguang,Peng, Jianhua,Jiang, WenJing,et al. mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo[J]. CANCER LETTERS,2013,341(2):186-194. |
APA | Yang, Chunguang., Peng, Jianhua., Jiang, WenJing., Zhang, Yue., Chen, Xiaoyun., ... & Jin, Kunlin. (2013). mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo. CANCER LETTERS, 341(2), 186-194. |
MLA | Yang, Chunguang,et al."mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo".CANCER LETTERS 341.2(2013):186-194. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论